Last updated: April 24, 2026

Application No. 19/363,223

Untitled Application

Unknown

Filed

1600

Examiner

PAK, MICHAEL D

Art Unit

1674

Tech Center

MORPHOSYS GMBH

Assignee

Morphosys GmbH

OA Round

1 (Non-Final)

This examiner grants 58% of cases after interview

— +30.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 694 resolved cases, 2023–2026

Examiner Intelligence

PAK, MICHAEL D View full profile →

Grants 58% of resolved cases

Career Allow Rate

405 granted / 694 resolved

-1.6% vs TC avg

Strong +31% interview lift

Without

With

+30.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 10m

Avg Prosecution

27 currently pending

Career history

721

Total Applications

across all art units

Statute-Specific Performance

§101

7.5%

-32.5% vs TC avg

§103

21.6%

-18.4% vs TC avg

§102

24.3%

-15.7% vs TC avg

§112

33.6%

-6.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 694 resolved cases

Prosecution Timeline

1600

Application Filed

Precedent Cases

Applications granted by this same examiner with similar technology

17/439,367

Patent 12595292

Interleukin-2 receptor (IL2R) and interleukin-2 (IL2) variants for specific activation of immune effector cells

2y 5m to grant Granted Apr 07, 2026

17/590,712

Patent 12590959

SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY

2y 5m to grant Granted Mar 31, 2026

18/053,432

Patent 12577288

METHODS AND COMPOSITIONS RELATING TO CHIMERIC ANTIGEN RECEPTORS

2y 5m to grant Granted Mar 17, 2026

18/505,864

Patent 12559562

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR

2y 5m to grant Granted Feb 24, 2026

17/059,539

Patent 12551531

NOVEL INTERLEUKIN-2 AND USE THEREOF

2y 5m to grant Granted Feb 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

58%

Grant Probability

89%

With Interview (+30.7%)

3y 10m

Median Time to Grant

Low

PTA Risk

Based on 694 resolved cases by this examiner. Grant probability derived from career allow rate.